Assessment of Communication Strategies for Mitigating COVID-19 Vaccine-Specific Hesitancy in Canada

Abstract

IMPORTANCE Ensuring widespread uptake of available COVID-19 vaccinations, each with different safety and efficacy profiles, is essential to combating the unfolding pandemic. OBJECTIVE To test communication interventions that may encourage the uptake of less-preferred vaccines. DESIGN, SETTING, AND PARTICIPANTS This online survey was conducted from March 24 to 30, 2021, using a nonprobability convenience sample of Canadian citizens aged 18 years or older, with quota sampling to match 2016 Canadian Census benchmarks on age, gender, region, and language.Respondents completed a 2-by-2-by-2 factorial experiment with random assignment of brand (AstraZeneca or Johnson & Johnson), information about the vaccine's effectiveness against symptomatic infection (yes or no), and information about the vaccine's effectiveness at preventing death from COVID-19 (yes or no) before being asked about their willingness to receive their assigned vaccine and their beliefs about its effectiveness. EXPOSURES Respondents were randomly assigned a vaccine brand (AstraZeneca or Johnson &Johnson) and information about the vaccine's effectiveness against symptomatic COVID-19 infection (yes or no) and at preventing death from COVID-19 (yes or no). MAIN OUTCOMES AND MEASURESRespondents' self-reported likelihood of taking their assigned vaccine if offered (response categories: very likely, somewhat likely, not very likely, or not at all likely, scaled 0-1) and their beliefs about their assigned vaccine's effectiveness (response categories: very effective, somewhat effective, not very effective, or not at all effective, scaled 0-1) were measured. RESULTS A total of 2556 Canadian adults responded to the survey (median [IQR] age, 50 years; 1339 women [52%]). The self-reported likelihood of taking an assigned AstraZeneca or Johnson & Johnson vaccine was higher for respondents given information about their assigned vaccine's effectiveness at preventing death from COVID-19 (b, 0.04; 95% CI, 0.01 to 0.06) and lower among those given information about its overall effectiveness at preventing symptomatic transmission (b, −0.03; 95% CI, −0.05 to 0.00), compared with those who were not given the information. Perceived effectiveness was also higher among those given information about their assigned vaccine's effectiveness at preventing death from COVID-19 (b, 0.03; 95% CI, 0.01 to 0.05) and lower among those given information about their assigned vaccine's overall efficacy at preventing symptomatic infection (b, −0.05; 95% CI, −0.08 to −0.03), compared with those who were not given this information. The interaction between these treatments was neither substantively nor statistically significant. CONCLUSIONS AND RELEVANCEThese findings suggest that providing information on the effectiveness of less-preferred vaccines at preventing death from COVID-19 is associated with more (continued) Key Points Question Are there communication strategies that can reduce COVID-19 vaccine-specific hesitancy? Findings In a between-participants survey study of adult Canadian citi...

Understanding of and Trust in the Centers for Disease Control and Prevention’s Revised COVID-19 Isolation and Quarantine Guidance Among US Adults

“…5 This omission is notable in light of evidence that highlighting protection against death may reduce COVID-19 vaccine hesitancy. 6 Limitations of the study include that it was conducted only online, such that individuals without internet access may have been undersampled, and use of a nonprobability sample, which limits generalizability to the US population as a whole.…”

“…5 This omission is notable in light of evidence that highlighting protection against death may reduce COVID-19 vaccine hesitancy. 6…”

The path towards herd immunity: Predicting COVID-19 vaccination uptake through results from a stated choice study across six continents

“…Finally, a crucial component of a globally successful vaccination campaign could be improved messaging, as highlighted for example by Beckman et al (2021) ; Merkley and Loewen (2021) ; Rief (2021) . Earlier work by Chanel et al (2011) stressed the beneficial impact on vaccine uptake of information provided by medical staff as opposed to media and internet, a finding repeated by Solís Arce et al (2021) in a COVID-19 context.…”

Which vaccine attributes foster vaccine uptake? A cross-country conjoint experiment

“…Hence, we do not know to what extent a common understanding of vaccine attributes such as side effects and effectiveness exists. Future research should be more aware of this aspect (see [ 47 ]).…”